Molecular Therapeutics Theme 3 Accomplishments

Theme 3: Validate clinical effectiveness of new agents and new protocols in interventional treatment trials

Scientific Accomplishments

In preclinical triple-negative breast cancer (TNBC) models, Drs. Boerner, Polin and Heilbrun, working with Dr. LoRusso, found that poly (ADP-ribose) polymerase (PARP) inhibitors such as veliparib (ABT-888) enhanced the activity of the topoisomerase 1 inhibitor irinotecan (CPT-11). Based on these results, a Phase I clinical trial was performed to examine the tolerability of combined veliparib/ironotecan in advanced solid tumor patients. Following the dose-escalation phase, an expansion cohort was opened to perform further biomarker and genomic correlative studies in two specific TNBC populations with the combined veliparib/irinotecan.

  • Lead researchers - Drs. Boerner, Polin and Heilbrun.
  • Collaborative researcher - Dr. Li

Dr. Gadgeelwas a Principal Investigators on a phase I/II study evaluating CH5424802 (alectinib), a second generation ALK (anaplastic lymphoma kinase) inhibitor in patients with ALK positive NSCLC (non-small cell lung cancer) whose disease had progressed following treatment with the first generation ALK inhibitor crizotinib. Based on the results of the phase II trial, the drug has received ‘breakthrough designation’ by the US FDA.

  • Lead researchers - Dr. Gadgeel

The Latest From Karmanos Cancer Institute

News

Cancer is No Match for Wife's Persistence

When John Deitering’s annual prostate specific antigen (PSA) came back elevated, his long-time family doctor referred him to a urologist to get hi...

Read More

Dr. George Yoo Named in Becker’s 2024 Chief Medical Officers to Know

George Yoo, M.D., FACS , chief medical officer (CMO) at Karmanos Cancer Hospital, was listed on Becker’s Hospital Review’s 2024 Chief Medical Offi...

Read More

Karmanos Welcomes Wasif Saif, M.D., to Lead Phase I Clinical Trials

The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS , as the new leader of the Phase I Clinical Trials Multidisciplinary Tea...

Read More
News

WWJ | Genetic Counselor Available to Speak with at Screening Saves Lives Event on June 8

Listen Now

WWJ | Screening Saves Lives Event Gives Participants Opportunity to Talk to Genetic Counselor

Listen Now

WWJ | Spotlight on Generosity: Bob Marzolf

Listen Now